Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

PLATO BRACHYTHERAPHY TREATMENT PLANNING SYSTEM

K-Number: K915622 · 1992-09-25

ApplicantNucletron-Oldelft Corp.
Decision Date1992-09-25
Product CodeJAQ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

PLATO BRACHYTHERAPHY TREATMENT PLANNING SYSTEM is the device name listed in this FDA 510(k) record. The listed applicant is Nucletron-Oldelft Corp.. It received FDA 510(k) clearance on 1992-09-25 under 510(k) number K915622. The device is classified under product code JAQ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the PLATO BRACHYTHERAPHY TREATMENT PLANNING SYSTEM?

PLATO BRACHYTHERAPHY TREATMENT PLANNING SYSTEM is a medical device that received FDA 510(k) clearance on 1992-09-25. The listed applicant is Nucletron-Oldelft Corp.. The 510(k) number is K915622.

When did PLATO BRACHYTHERAPHY TREATMENT PLANNING SYSTEM receive FDA 510(k) clearance?

PLATO BRACHYTHERAPHY TREATMENT PLANNING SYSTEM received FDA 510(k) clearance on 1992-09-25, under 510(k) number K915622.

Who is the listed applicant for PLATO BRACHYTHERAPHY TREATMENT PLANNING SYSTEM?

The FDA 510(k) record lists Nucletron-Oldelft Corp. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for PLATO BRACHYTHERAPHY TREATMENT PLANNING SYSTEM?

The FDA product code for PLATO BRACHYTHERAPHY TREATMENT PLANNING SYSTEM is JAQ.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Nucletron-Oldelft Corp. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K953946MICROSELECTRON-HDR VERSION 2K953831N 800 HFK925956MICROSELECTRON - HDR FOR MOBILE ENVIRONMENTK926407MODEL COLE TAB-2 TABLE W/MODEL COLE SFD-2 SPOTFILMK921991PLATO RADIATION THERAPY PLANNING SYSTEMK911612NUCLETRON PLANNING SYSTEM

View all 11 devices →

Related Devices (Code: JAQ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K262383LumenCare AzureNucletron B.V.K252717MAASTRO Rectal Applicator SetVarian Medical SystemsK251037Rectal ApplicatorNucletron B.V.K252884Guided Aarhus Applicator SetVarian Medical SystemsK250299CT/ MR Tandem and Ovoid SetVarian Medical Systems, Inc.K250289Intracavitary/Interstitial SystemVarian Medical Systems

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑